subject area of
- Brief Review: Rivastigmine, A Second Cholinesterase Inhibitor Academic Article
- Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians Academic Article
- Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness Academic Article
- Economic Evaluation of Rivastigmine in Patients with Parkinson??s Disease Dementia Academic Article
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline Academic Article
- Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis Academic Article
- Reduced Tissue Levels of Noradrenaline Are Associated with Behavioral Phenotypes of the TgCRND8 Mouse Model of Alzheimer's Disease Academic Article
- Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study Academic Article